Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Gorana Capkun's publication output changed over time?
ScholarIQpublication output · 2005–2022
Output grew100% over the shown period — from 1 works in 2005 to 2 in 2022.
1
1
2
3
1
1
2
2005201320142015201720212022
What are the most-cited papers on Gorana Capkun?
ScholarIQmost cited works
Mortality and comorbidities in patients with multiple sclerosis compared with a population without multiple sclerosis: An observational study using the US Department of Defense administrative claims database
Gorana Capkun, Frank Dahlke, Raquel Lahoz, Beth Nordstrom, Hugh H. Tilson, Gary Cutter, Dorina Bischof, Alan Moore, Jason C. Simeone, Kathy Fraeman, Fabrice Bancken, Yvonne Geissbühler, Michael Wagner, Stanley Cohan
S2764622253. 2015116 CitationsOPEN ACCESS
Persistence with and adherence to fingolimod compared with other disease-modifying therapies for the treatment of multiple sclerosis: a retrospective US claims database analysis
Niklas Bergvall, Allison Petrilla, Swapna Karkare, Raquel Lahoz, Neetu Agashivala, Ashish Pradhan, Gorana Capkun, Charles Makin, Catherine B. McGuiness, Jonathan R. Korn
Journal of Medical Economics. 201491 CitationsOPEN ACCESS
A Systematic Review and Meta-Analysis of Prevalence Studies of Sporadic Inclusion Body Myositis
Aoife Callan, Gorana Capkun, Vijayalakshmi Vasanthaprasad, Rita Freitas, Merrilee Needham
Journal of Neuromuscular Diseases. 201781 Citations
Relapse Rates in Patients with Multiple Sclerosis Switching from Interferon to Fingolimod or Glatiramer Acetate: A US Claims Database Study
Niklas Bergvall, Charles Makin, Raquel Lahoz, Neetu Agashivala, Ashish Pradhan, Gorana Capkun, Allison Petrilla, Swapna Karkare, Catherine B. McGuiness, Jonathan R. Korn
PLoS ONE. 201470 CitationsOPEN ACCESS
Network meta-analysis combining individual patient and aggregate data from a mixture of study designs with an application to pulmonary arterial hypertension
Howard Thom, Gorana Capkun, Annamaria Cerulli, Richard M. Nixon, Luke Howard
BMC Medical Research Methodology. 201566 CitationsOPEN ACCESS
Related on ScholarIQ
Merck KGaA, Darmstadt (Germany)
Institution
Mortality and comorbidities in patients with multiple sclerosis compared with a population without multiple sclerosis: An observational study using the US Department of Defense administrative claims database
Paper
Persistence with and adherence to fingolimod compared with other disease-modifying therapies for the treatment of multiple sclerosis: a retrospective US claims database analysis
Paper
A Systematic Review and Meta-Analysis of Prevalence Studies of Sporadic Inclusion Body Myositis
Paper
Relapse Rates in Patients with Multiple Sclerosis Switching from Interferon to Fingolimod or Glatiramer Acetate: A US Claims Database Study
Paper
Network meta-analysis combining individual patient and aggregate data from a mixture of study designs with an application to pulmonary arterial hypertension
Paper